Orally Available Selective Melanocortin-4 Receptor Antagonists Stimulate Food Intake and Reduce Cancer-Induced Cachexia in Mice

Philipp Weyermann, Robert Dallmann, Josef Magyar et al. · 2009

Read Orally Available Selective Melanocortin-4 Receptor Antagonists Stimulate Food Intake and Reduce Cancer-Induced Cachexia in Mice by Philipp Weyermann, Robert Dallmann, Josef Magyar et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004774.txt.

Description

Philipp Weyermann and colleagues tested oral blockers of a feeding receptor that boost intake and ease cancer wasting in mice, in PLOS ONE in 2009. Cancer cachexia is a wasting syndrome with loss of appetite, fat, and muscle. It is among the most debilitating parts of cancer and can threaten life on its own.

A brain peptide that suppresses appetite acts through the receptor targeted here. Blocking that receptor by mouth raised food intake in the mice. It also reduced wasting tied to tumors. The approach could help patients keep strength during treatment. The work also raises clear questions that targeted studies can now address.

Catalog record

CREATORPhilipp Weyermann, Robert Dallmann, Josef Magyar et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004774

Browse the full library · About the Tower of Babel